Trial Profile
Phase IIb/III study of IRT 103 in patients with HIV
Status:
Planning
Phase of Trial:
Phase II/III
Latest Information Update: 21 Jun 2023
Price :
$35
*
At a glance
- Drugs Naltrexone (Primary)
- Indications HIV infections
- Focus Therapeutic Use
- 06 Oct 2016 New trial record